Cansor

Curated by Signal

Provider of point-of-care test for cancer diagnosis

Overview

Provider of point-of-care test for cancer diagnosis. It offers blood test for prostate cancer using cell-free DNA and state-of-art AI technology to detect prostate cancer and other cancer types.

Key facts

Founded: 2021
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Diagnostics.ai
Developer of AI-based automated diagnostics platform
Life Sciences TechnologyBarnet, United Kingdom
Brainminer
Provider of machine learning based diagnostic platform for neurology
Life Sciences TechnologyLondon, United Kingdom
DNAFit
Provider of genetics based personalized fitness recommendations
Life Sciences TechnologyLondon, United Kingdom

About Cansor

What does Cansor do?

Provider of point-of-care test for cancer diagnosis.

Where is Cansor headquartered?

Cansor is headquartered in London, United Kingdom.

When was Cansor founded?

Cansor was founded in 2021.

Which sector is Cansor in?

Cansor operates in Life Sciences Technology.

Who are Cansor's competitors?

Companies similar to Cansor include Diagnostics.ai, Brainminer, and DNAFit.